Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 15251 - 15275 of 15501 in total
5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole is a solid. This compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. Known drug targets of 5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole include genome polyprotein.
Experimental
UK-390,957 has been used in trials studying the treatment of Ejaculation.
Investigational
Talinolol has been investigated for the basic science of Gastrointestinal Motility Disorder.
Investigational
Dapaconazole has been used in trials studying the treatment of Tinea Pedis.
Investigational
Azeliragon has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Ritanserin has been used in trials studying the treatment of Cocaine-Related Disorders.
Investigational
TBD has been used in trials studying the treatment of Adenocarcinoma.
Investigational
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
CRx-139 is an oral synergistic combination drug candidates with novel mechanisms of action targeting multiple biological pathways simultaneously. It is a dissociated steroid designed to enhance the immuno-modulatory activity of a low-dose glucocorticoid steroid without a comparable increase in steroid-related side effects. The synergistic combination containing low doses of the...
Investigational
Matched Description: … The synergistic combination containing low doses of the glucocorticoid steroid prednisolone and the antidepressant …
CG0070 is investigated in clinical trials for treating bladder cancer. CG0070 is a solid. CG0070 can potentially destroy cancer cells by two different mechanisms: direct cell killing by the virus and immune-mediated cell killing stimulated by GM-CSF. CG0070, an oncolytic virus therapy with specificity for multiple cancers, has been evaluated...
Investigational
Matched Description: … can potentially destroy cancer cells by two different mechanisms: direct cell killing by the virus and
4SC-203 has been used in trials studying the treatment of Acute Myeloid Leukemia.
Investigational
Experimental
Illicit
Displaying drugs 15251 - 15275 of 15501 in total